JESSICA HUFF: Open Payments
NPI 1245700442 · SHEPHERDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $288 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $155 |
| ABIOMED | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| PFIZER INC. | 2 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, FARXIGA, ONPATTRO, ELIQUIS, Wegovy, Kerendia, CAPVAXIVE, VERQUVO.
Industry payments across KY — which companies pay providers there.
